KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Other Operating Expenses (2016 - 2019)

Eli Lilly (LLY) has disclosed Other Operating Expenses for 8 consecutive years, with -$151.7 million as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Other Operating Expenses fell 519.18% year-over-year to -$151.7 million, compared with a TTM value of -$151.7 million through Sep 2020, up 66.17%, and an annual FY2019 reading of -$9.1 billion, down 10.93% over the prior year.
  • Other Operating Expenses was -$151.7 million for Q4 2019 at Eli Lilly, up from -$423.9 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $5.0 billion in Q4 2016 and bottomed at -$423.9 million in Q1 2019.
  • Average Other Operating Expenses over 5 years is $324.4 million, with a median of -$56.8 million recorded in 2018.
  • The sharpest move saw Other Operating Expenses surged 3526.71% in 2016, then crashed 646.3% in 2019.
  • Year by year, Other Operating Expenses stood at -$144.9 million in 2015, then soared by 3526.71% to $5.0 billion in 2016, then plummeted by 102.88% to -$142.9 million in 2017, then soared by 82.86% to -$24.5 million in 2018, then tumbled by 519.18% to -$151.7 million in 2019.
  • Business Quant data shows Other Operating Expenses for LLY at -$151.7 million in Q4 2019, -$423.9 million in Q1 2019, and -$24.5 million in Q4 2018.